Suchergebnisse - "Hoyos, Montserrat"

PubPharm (20)

1

Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1

enthalten in: Blood advances | 2022

von Oñate, G. | Bataller, A. | Garrido, A. | +15

ErratumIn: Blood Adv. 2023 Mar 14;7(5):875. - PMID 36917130

2

Genetic characterization of acute myeloid leukemia patients with mutations in IDH1/2 genes

enthalten in: Leukemia research | 2021

von Acha, P. | Hoyos, M. | Pratcorona, M. | +20

3

Bone marrow WT1 levels in patients with myeloid neoplasms treated with 5-azacytidine : Identification of responding patients

enthalten in: European journal of haematology | 2019

von Santaliestra, M. | Garrido, A. | Carricondo, M. | +11

4

Bone marrow WT1 levels in patients with myeloid neoplasms treated with 5‐azacytidine : Identification of responding patients

enthalten in: European Journal of Haematology | 2019

von Santaliestra, M. | Garrido, A. | Carricondo, M. | +11

5

Focal Adhesion Genes Refine the Intermediate-Risk Cytogenetic Classification of Acute Myeloid Leukemia

enthalten in: Cancers | 2018

von Pallarès, V. | Hoyos, M. | Chillón, M. | +13

6

Bone marrow VEGFC expression is associated with multilineage dysplasia and several prognostic markers in adult acute myeloid leukemia, but not with survival

enthalten in: Leukemia & lymphoma | 2018

von Guillem, V. | Calabuig, M. | Brunet, S. | +22

7

Bone Marrow WT1 Levels in Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplasia : Clinically Relevant Time Points and 100 Copies Threshold Value

enthalten in: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation | 2018

von Nomdedéu, J. | Esquirol, A. | Carricondo, M. | +10

8

NEDD9, an independent good prognostic factor in intermediate-risk acute myeloid leukemia patients

enthalten in: Oncotarget | 2017

von Pallarès, V. | Hoyos, M. | Chillón, M. | +11

9

The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature

enthalten in: Oncotarget | 2015

von Díaz-Beyá, M. | Brunet, S. | Nomdedéu, J. | +19

10

Complex measurements may be required to establish the prognostic impact of immunophenotypic markers in AML

enthalten in: American journal of clinical pathology | 2015

von García-Dabrio, M. | Hoyos, M. | Brunet, S. | +16